Acetylsalicylic acid Terminated Phase 3 Trials for Strokes Prevention

IndicationsStatusPurposePhase
TerminatedPrevention3
clinicaltrials.gov IdentifierTitleDrugs
NCT02313909Rivaroxaban Versus Aspirin in Secondary Prevention of Stroke and Prevention of Systemic Embolism in Patients With Recent Embolic Stroke of Undetermined Source (ESUS)